Harrow Health, Inc.
HROW
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of theā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$50.37
Price+0.33%
$0.17
1Y
Price
Market Cap
$1.865b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+25.6%
EBITDA Margin+7.8%
Net Profit Margin-1.4%
Free Cash Flow MarginRevenue
$227.661m
+14.1%
1y CAGR+38.1%
3y CAGR+34.1%
5y CAGREarnings
-$10.228m
+41.5%
1y CAGR-1.1%
3y CAGR+4.6%
5y CAGREPS
-$0.30
+38.8%
1y CAGR+8.8%
3y CAGR+13.1%
5y CAGRBook Value
$49.299m
$345.033m
Assets$295.734m
Liabilities$231.251m
DebtDebt to Assets
67.0%
7.2x
Debt to EBITDAFree Cash Flow
-$34.382m
+43.5%
1y CAGR-749.4%
3y CAGR-543.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company